Dr. Denise Frances Mackey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1800 W. Big Beaver Rd, Suite 200, Troy, MI 48084 Phone: 248-205-3535 Fax: 248-649-5920 |
Jonathan Lauter, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1800 W Big Beaver Rd Ste 200, Troy, MI 48084 Phone: 248-205-3535 Fax: 248-649-5920 |
Dr. Paige Summer Demos, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5000 |
Dr. Hanit Kalo, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44199 Dequindre Rd, Suite 222, Troy, MI 48085 Phone: 248-879-5570 Fax: 248-879-2235 |
Sachin K Shah, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1007 Alameda Blvd, Troy, MI 48085 Phone: 773-636-9945 |
News Archive
With severe blood disorders, such as leukemia, doctors often rely on leukapheresis, a procedure in which large machines extract whole blood from patients to separate white blood cells from the rest of the blood, which is then returned back to the patient.
Molecular biologist Alan Ashworth, Ph.D., FRS, the director of the Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research in London will receive the David T. Workman Memorial Award on May 17. The two-year grant of $50,000 from the Samuel Waxman Cancer Research Foundation will support Dr. Ashworth's work with PARP inhibitors in BRCA-mutated cancers.
Receiving a blood transfusion in the intensive care unit (ICU) is not uncommon, but reliable predictors for patients that will require transfusion are not readily available. A new study published in the May issue of Anesthesiology seeks to reduce the occurrence of ICU transfusions, revealing a new marker for patients at higher risk for developing severe anemia and subsequently requiring transfusion in the ICU.
Repeated exposure to a common anesthesia drug early in life results in visual recognition memory impairment, which emerges after the first year of life and may persist long-term, according to a study from the Icahn School of Medicine at Mount Sinai and published online May 31 in the British Journal of Anaesthesia.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 7 days ago